Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qishi Shengjiang Guiyuan Granules
- Development stage
- Preclinical
- Lead developer
- Guangxi University of Chinese Medicine First Affiliated Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qishi Shengjiang Guiyuan Granules (芪石升降归元颗粒) is a traditional Chinese medicine (TCM) compound granule formulation developed and prepared by the First Affiliated Hospital of Guangxi University of Chinese Medicine. It is used in clinical practice as a hospital-prepared TCM product. The formula combines multiple herbal ingredients, with its name suggesting the inclusion of Astragalus (Huangqi), stone-based minerals, and herbs that "raise and lower" Qi to restore balance to the body's Yuan (original energy). Preclinical studies indicate potential effects in alleviating symptoms related to gastroesophageal reflux disease (GERD), including pulmonary and airway inflammation associated with GERD[7][9]. The mechanism is believed to involve multi-target regulation typical of TCM formulas; however, specific molecular targets or pathways have not been fully elucidated. The granule form allows for convenient oral administration[2].
- Brand names
- Qishi Shengjiang Guiyuan Granules芪石升降归元颗粒
- Other names
- 芪石升降归元颗粒
Beyond the preview
Go deeper on Qishi Shengjiang Guiyuan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qishi Shengjiang Guiyuan Granules.